Detailed explanation of the onset time and influencing factors of selinesol treatment

Selinexor (Selinexor), as an innovative targeted therapy, has been approved for the treatment of multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL). Unlike traditional chemotherapy drugs, it works by precisely identifying and attaching to specific cellular targets, such as certain proteins, thereby enabling targeted cancer treatment. This also makes selinesol the first targeted therapy approved by the U.S. Food and Drug Administration (FDA) using this unique mechanism of action.

Selinexor’s core active ingredient isselinexor, a groundbreaking selective inhibitor of nuclear export (SINE). It can accurately target cancer cells containing the XPO1 protein and effectively inhibit the function of this protein after attachment. Because levels of the XPO1 protein are abnormally elevated in some cancer types, selinesol's mechanism of action can specifically trigger cancer cell death.

Although selinexol works quickly after you start taking it, patients may not feel its effects right away. According to data from clinical studies, some patients begin to respond to the drug after taking selinexol for 1 to 2 months. However, the exact time it takes to start working can vary depending on a variety of factors, including the type of cancer being treated, the severity of the disease, and individual patient differences. Therefore, some people may see significant improvement within a short period of time, while for others it may take longer to observe positive treatment effects.

Doctors consider a variety of factors when determining the dose of selinesol, including the type and stage of the cancer, the patient's overall health and whether they are taking other medications. Typically, doctors will start patients on higher doses to see how well they work and how well they are tolerated. If the patient develops intolerance or severe side effects, the doctor will adjust the dose according to the situation to find the most suitable treatment plan for the patient. It's important to note that selinesol is generally designed as a long-term treatment, and patients may need to continue taking it until their cancer progresses or they develop uncontrollable side effects.